Posts Tagged ‘NASA’

NASA Solicitation: Technology Demonstration Missions BAA

Tuesday, March 8th, 2011

Synopsis – Mar 01, 2011

General Information

Solicitation Number: NNM11ZDA001KPosted Date: Mar 01, 2011FedBizOpps Posted Date: Mar 01, 2011Recovery and Reinvestment Act Action: NoOriginal Response Date: May 31, 2011Current Response Date: May 31, 2011Classification Code: A — Research and DevelopmentNAICS Code: 541712 – Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Contracting Office Address

NASA/George C. Marshall Space Flight Center, Procurement Office, Marshall Space Flight Center, AL 35812

Description

The National Aeronautics and Space Administration (NASA) Marshall Space Flight Center is releasing a Technology Demonstration Missions (TDM) Broad Agency Announcement (BAA) in support of the Office of Chief Technologist (OCT). The BAA will be available on March 1, 2011, by opening the NASA Research Opportunities homepage at http://nspires.nasaprs.com/ and then linking through the menu listings “Solicitations” to “Open Solicitations.”

This announcement solicits proposals for the demonstration of space technologies that provide new system-level technological capabilities. OCT TDM is seeking to identify candidate crosscutting, system-level technologies to be demonstrated in the relevant environment such as ground, air, suborbital or orbital regimes. A key requirement in this program is that the technology under consideration must clearly be crosscutting. Crosscutting is defined as a technology with potential to benefit more than one customer, where a customer can be a NASA Mission Directorate, another government agency, academia, or the aerospace industry. Specifically, “system-level technologies” implies an integrated system with mission capability and not component-level demonstrations. OCT is seeking new capability demonstrations that advance the technology readiness of the selected systems, provide tangible, innovative technology products, are cost effective, and capture significant public interest and awareness. The candidate technology must be mature, at least Technology Readiness Level (TRL) 5 at the time of the proposal submission, and the proposed demonstration must raise the technology readiness of the new capability, to TRL 7 or higher, such that it may be infused into the critical path for future missions.

This announcement solicits technology demonstration proposals in the following four focused technology areas:

High Bandwidth Deep Space Communication, Navigation, and Timing Communication and navigation are enabling services that are required by all spacecraft. Advancement in communication and navigation technology will allow future missions to implement new and more capable science instruments, greatly enhance human missions beyond Earth orbit, and enable entirely new mission concepts. Future mission requirements drive the need for increased navigation precision and enhanced communication solutions. Demonstrations that advance high bandwidth deep space communications capabilities are of interest. Navigation technologies that significantly enhance timing accuracy as well as autonomous navigation techniques for precise spacecraft maneuvers are of interest. Systems that integrate technology developed across communication and navigation are also of interest. The capability can be self-contained or distributed, such as a constellation of two or more spacecraft flying in relatively close formation that together demonstrate an aperture or baseline that is larger and more capable.

Orbital Debris Mitigation or Removal Systems Over the course of 50+ years of space activities, over 500,000 man-made objects have accumulated in Earth orbit, ranging from low to geosynchronous altitudes and beyond. These objects pose long-term dangers to current and future space missions. Once these objects are accurately located and tracked, methods must be developed to de-orbit, destroy, collect, or divert these objects. This solicitation seeks proposals for the demonstration of systems capable of mitigation or removal of small debris (1-10 centimeters), as well as systems capable of mitigation or removal of large objects (10+ centimeters) from Earth orbit.

Advanced In-Space Propulsion Systems In-space propulsion begins where launch vehicle upper stage propulsion leaves off, providing primary propulsion and orbital maneuvering capabilities. Advanced in-space propulsion technologies will enable much more effective exploration of the solar system by allowing mission designers to plan more robust missions with shorter trip times and lower costs. This solicitation is seeking proposals to demonstrate novel in-space systems providing primary propulsion capabilities. Systems utilizing green propellants, solar sails, tethers, beamed-energy propulsion and other advanced systems are of interest. Note: Solar Electric Propulsion, Nuclear systems and Aerocapture technology demonstration missions are not solicited in this BAA.

Autonomous Rendezvous, Docking, Close Proximity Operations and Formation Flying The ability of space assets to autonomously rendezvous and dock enables human and science exploration, as well as satellite servicing/rescue, and is an essential capability for the future of human and robotic missions. One of the challenges for autonomous rendezvous and docking is proximity operations. Proximity operations to targets such as spacecraft, space telescopes or Near Earth Objects (NEOs) will require advanced autonomous rendezvous and coupling technologies. Objects like NEOs that lack docking infrastructure, and may also be tumbling, are particularly challenging. This solicitation is seeking demonstrations of full autonomy and automation of rendezvous, docking, close proximity operations and formation flying that would provide future missions with a ready-to-fly capability that is reliable, versatile, cost-effective, and could be utilized in either low Earth orbit or deep space.

For crosscutting space technology demonstrations, such as those sought in this BAA, cost sharing (a goal of at least 25% is desired) of the total life cycle costs from a source other than NASA OCT is required. Cost sharing can be through in-kind contributions and/or funding provided after ATP. A signed, dated Letter of Commitment shall be provided from source(s) funding or in-kind contributions outside of OCT. It is anticipated that firm-fixed-price contracts with priced options will be awarded for this effort. An appropriate interagency or intra-agency agreement will be used for awardees of Federal entities.

Proposals shall be submitted electronically, and all proposers shall use NASA’s proposal data system, NSPIRES (http://nspires.nasaprs.com ). In addition, the electronic proposals must be submitted by an authorized official of the proposing organization. Participation is open to all categories of organizations, including educational institutions, industry, nonprofit organizations, Federally Funded Research and Development Centers (FFRDCs), University Affiliated Research Centers (UARCs), the Jet Propulsion Laboratory (JPL), NASA Centers, and other Government agencies. Every organization that intends to submit a proposal in response to this BAA must be registered with NSPIRES, and such registration must identify the authorized organizational representative(s) who will submit the electronic proposal. Potential proposers and proposing organizations are urged to access the electronic proposal system(s) well in advance of the proposal due date(s) to familiarize themselves with its structure and enter the requested information. Specific proposal submission deadline dates, evaluation criteria, and submission information will be identified in the BAA. Proposals will be due on May 31, 2011.

Awards based on this solicitation are contingent on availability of appropriated funds.

Obtain additional programmatic information from: Bonnie James/NASA HQ Email: bonnie.f.james@nasa.gov

Point of Contact

Name: Mark R. StilesTitle: Contracting OfficerPhone: 256-544-0381Fax: 256-544-6062Email: mark.r.stiles@nasa.gov

View full post on technology – Yahoo! News Search Results

NASA Light Technology Helps Cancer Patients

Monday, March 7th, 2011

NASA Light Technology Helps Cancer Patients
by Staff Writers Huntsville AL (SPX) Mar 04, 2011 A NASA technology originally developed for plant growth experiments on space shuttle missions has successfully reduced the painful side effects resulting from chemotherapy and radiation treatment in bone marrow and stem cell transplant patients.

In a two-year clinical trial, cancer patients undergoing bone marrow or stem cell transplants were given a far red/near infrared Light Emitting Diode treatment called High Emissivity Aluminiferous Luminescent Substrate, or HEALS, to treat oral mucositis – a common and extremely painful side effect of chemotherapy and radiation treatment.

The trial concluded that there is a 96 percent chance that the improvement in pain of those in the high-risk patient group was the result of the HEALS treatment.

“Using this technology as a healing agent was phenomenal,” said Dr. Donna Salzman, clinical trial principal investigator and director of clinical services and education at the Bone Marrow Transplant and Cellular Therapy Unit at the University of Alabama at Birmingham Hospital. “The HEALS device was well tolerated with no adverse affects to our bone marrow and stem cell transplant patients.”

The HEALS device, known as the WARP 75 light delivery system, can provide a cost-effective therapy since the device itself is less expensive than a day at the hospital and a proactive therapy for symptoms of mucositis that are currently difficult to treat without additional, negative side effects.

The device could offer patients several benefits: better nutrition since eating can be difficult with painful mouth and throat sores; less narcotic use to treat mouth and throat pain; and an increase in patient morale – all of which can contribute to shorter hospital stays and less potential for infection, added Salzman.

LEDs are light sources releasing energy in the form of photons. They release long wavelengths of light that stimulate cells to aid in healing. HEALS technology allows LED chips to function at their maximum irradiancy without emitting heat. NASA is interested in using HEALS technology for medical uses to improve healing in space and for long-term human spaceflight.

Ron Ignatius, founder and chairman of Quantum Devices Inc., of Barneveld Wis., developed the WARP 75 light delivery system for use in the trial. The device uses the HEALS technology to provide intense light energy: the equivalent light energy of 12 suns from each of the 288 LED chips – each the size of a grain of salt. It is one of many devices using HEALS technology, developed in collaboration with NASA.

In the early 1990s, Quantum teamed with the Wisconsin Center for Space Automation and Robotics – a NASA-sponsored research center at the University of Wisconsin-Madison – to develop Astroculture 3, a plant growth chamber using near infrared HEALS technology for plant growth experiments on shuttle missions. Over the years, Quantum has worked to develop HEALS technology for use in medical fields, specifically with pediatric brain tumors and hard-to-heal wounds such as diabetic skin ulcers, serious burns and oral mucositis.

“With the help of NASA’s Innovative Partnerships Program, Quantum Devices and its medical partners have been able to take a space technology and adapt it for an entirely different application to significantly help people here on Earth,” said Glenn Ignatius, president of Quantum Devices. “This collaboration between NASA and commercial companies has spurred innovation that is touching millions of lives on Earth – for the better.”

The clinical trial was funded by NASA’s Innovative Partnerships Program at the Marshall Space Flight Center in Huntsville, Ala. It included 20 cancer patients from Children’s Hospital of Wisconsin and 60 cancer patients from the University of Alabama at Birmingham Hospital and the Children’s Hospital of Alabama, also in Birmingham.

The trial was the brainchild of Brian Hodgson, DDS, a pediatric dentist at Marquette University and Children’s Hospital of Wisconsin – both in Milwaukee, Wis. Dr. Harry T. Whelan, Bleser Professor of Neurology at the Medical College of Wisconsin, served as the clinical trial principal investigator at Medical College of Wisconsin and Children’s Hospital of Wisconsin.

Patients participated in the multi-center, double-blind, placebo-controlled research study – a way of testing a medical therapy where some groups receive treatment and others receive a placebo treatment that is designed to have no real effect.

Participants were randomly placed in one of four study groups: low- and high-risk patients receiving the experimental light therapy through the WARP 75 device, and other low- and high-risk patients receiving light through a similar device without therapeutic effects. The low-risk patients were those whose chemotherapy and radiation treatment tended to cause mild or no mucositis and the high-risk patients were those whose therapy treatment tended to cause severe cases of mucositis.

Patients received the light therapy by a nurse holding the WARP 75 device – about the size of an adult human hand – in close proximity to the outside of the patient’s left and right cheek and neck area for 88 seconds each, daily for 14 days at the start of the patient’s bone marrow or stem cell transplant. During that time, trained clinicians assessed the patient’s mouth and patients completed a simple form to indicate their level of pain.

“NASA is proud to be a part of the HEALS technology medical advancements that are improving the lives of cancer patients and providing new, innovative medical applications,” said Helen Stinson, technical monitor for the NASA HEALS contract. “It’s exciting to see the spinoffs from NASA’s science and technology initiatives continually improve the quality of life for people here on Earth.”

The WARP 75 device is currently undergoing Food and Drug Administration premarket approval.

Share This Article With Planet Earth

Related Links University of Alabama at Birmingham Hospital Space Medicine Technology and Systems


The Astrobiology Of Cancer Moffett Field (SPX) Feb 15, 2011 Despite decades of research and billions of dollars, cancer remains a major killer, with an uncanny ability to evade both the body’s defenses and medical intervention. Now an Arizona State University scientist believes he has an explanation. “Cancer is not a random bunch of selfish rogue cells behaving badly, but a highly-efficient pre-programmed response to stress, honed by a long period … read more

View full post on technology – Yahoo! News Search Results

NASA Light Technology Successfully Reduces Cancer Patients Painful Side … – Science Daily (press release)

Sunday, March 6th, 2011

ScienceDaily (Mar. 6, 2011) — A NASA technology originally developed for plant growth experiments on space shuttle missions has successfully reduced the painful side effects resulting from chemotherapy and radiation treatment in bone marrow and stem cell transplant patients.

In a two-year clinical trial, cancer patients undergoing bone marrow or stem cell transplants were given a far red/near infrared Light Emitting Diode treatment called High Emissivity Aluminiferous Luminescent Substrate, or HEALS, to treat oral mucositis — a common and extremely painful side effect of chemotherapy and radiation treatment. The trial concluded that there is a 96 percent chance that the improvement in pain of those in the high-risk patient group was the result of the HEALS treatment.

“Using this technology as a healing agent was phenomenal,” said Dr. Donna Salzman, clinical trial principal investigator and director of clinical services and education at the Bone Marrow Transplant and Cellular Therapy Unit at the University of Alabama at Birmingham Hospital. “The HEALS device was well tolerated with no adverse affects to our bone marrow and stem cell transplant patients.”

The HEALS device, known as the WARP 75 light delivery system, can provide a cost-effective therapy since the device itself is less expensive than a day at the hospital and a proactive therapy for symptoms of mucositis that are currently difficult to treat without additional, negative side effects.

The device could offer patients several benefits: better nutrition since eating can be difficult with painful mouth and throat sores; less narcotic use to treat mouth and throat pain; and an increase in patient morale — all of which can contribute to shorter hospital stays and less potential for infection, added Salzman.

LEDs are light sources releasing energy in the form of photons. They release long wavelengths of light that stimulate cells to aid in healing. HEALS technology allows LED chips to function at their maximum irradiancy without emitting heat. NASA is interested in using HEALS technology for medical uses to improve healing in space and for long-term human spaceflight.

Ron Ignatius, founder and chairman of Quantum Devices Inc., of Barneveld Wis., developed the WARP 75 light delivery system for use in the trial. The device uses the HEALS technology to provide intense light energy: the equivalent light energy of 12 suns from each of the 288 LED chips — each the size of a grain of salt. It is one of many devices using HEALS technology, developed in collaboration with NASA.

In the early 1990s, Quantum teamed with the Wisconsin Center for Space Automation and Robotics — a NASA-sponsored research center at the University of Wisconsin-Madison — to develop Astroculture 3, a plant growth chamber using near infrared HEALS technology for plant growth experiments on shuttle missions. Over the years, Quantum has worked to develop HEALS technology for use in medical fields, specifically with pediatric brain tumors and hard-to-heal wounds such as diabetic skin ulcers, serious burns and oral mucositis.

“With the help of NASA’s Innovative Partnerships Program, Quantum Devices and its medical partners have been able to take a space technology and adapt it for an entirely different application to significantly help people here on Earth,” said Glenn Ignatius, president of Quantum Devices. “This collaboration between NASA and commercial companies has spurred innovation that is touching millions of lives on Earth — for the better.”

The clinical trial was funded by NASA’s Innovative Partnerships Program at the Marshall Space Flight Center in Huntsville, Ala. It included 20 cancer patients from Children’s Hospital of Wisconsin and 60 cancer patients from the University of Alabama at Birmingham Hospital and the Children’s Hospital of Alabama, also in Birmingham. The trial was the brainchild of Brian Hodgson, DDS, a pediatric dentist at Marquette University and Children’s Hospital of Wisconsin — both in Milwaukee, Wis. Dr. Harry T. Whelan, Bleser Professor of Neurology at the Medical College of Wisconsin, served as the clinical trial principal investigator at Medical College of Wisconsin and Children’s Hospital of Wisconsin.

Patients participated in the multi-center, double-blind, placebo-controlled research study — a way of testing a medical therapy where some groups receive treatment and others receive a placebo treatment that is designed to have no real effect. Participants were randomly placed in one of four study groups: low- and high-risk patients receiving the experimental light therapy through the WARP 75 device, and other low- and high-risk patients receiving light through a similar device without therapeutic effects. The low-risk patients were those whose chemotherapy and radiation treatment tended to cause mild or no mucositis and the high-risk patients were those whose therapy treatment tended to cause severe cases of mucositis.

Patients received the light therapy by a nurse holding the WARP 75 device — about the size of an adult human hand — in close proximity to the outside of the patient’s left and right cheek and neck area for 88 seconds each, daily for 14 days at the start of the patient’s bone marrow or stem cell transplant. During that time, trained clinicians assessed the patient’s mouth and patients completed a simple form to indicate their level of pain.

“NASA is proud to be a part of the HEALS technology medical advancements that are improving the lives of cancer patients and providing new, innovative medical applications,” said Helen Stinson, technical monitor for the NASA HEALS contract. “It’s exciting to see the spinoffs from NASA’s science and technology initiatives continually improve the quality of life for people here on Earth.”

The WARP 75 device is currently undergoing Food and Drug Administration premarket approval.

Email or share this story:

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by NASA.

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

View full post on technology – Google News

NASA Light Technology Successfully Reduces Cancer Patients’ Painful Side Effects from Radiation and Chemotherapy

Friday, March 4th, 2011

image

HUNTSVILLE, Ala. – A NASA technology originally developed for plant growth experiments on space shuttle missions has successfully reduced the painful side effects resulting from chemotherapy and radiation treatment in bone marrow and stem cell transplant patients.

In a two-year clinical trial, cancer patients undergoing bone marrow or stem cell transplants were given a far red/near infrared Light Emitting Diode treatment called High Emissivity Aluminiferous Luminescent Substrate, or HEALS, to treat oral mucositis – a common and extremely painful side effect of chemotherapy and radiation treatment. The trial concluded that there is a 96 percent chance that the improvement in pain of those in the high-risk patient group was the result of the HEALS treatment.

“Using this technology as a healing agent was phenomenal,” said Dr. Donna Salzman, clinical trial principal investigator and director of clinical services and education at the Bone Marrow Transplant and Cellular Therapy Unit at the University of Alabama at Birmingham Hospital. “The HEALS device was well tolerated with no adverse affects to our bone marrow and stem cell transplant patients.”

The HEALS device, known as the WARP 75 light delivery system, can provide a cost-effective therapy since the device itself is less expensive than a day at the hospital and a proactive therapy for symptoms of mucositis that are currently difficult to treat without additional, negative side effects.

The device could offer patients several benefits: better nutrition since eating can be difficult with painful mouth and throat sores; less narcotic use to treat mouth and throat pain; and an increase in patient morale – all of which can contribute to shorter hospital stays and less potential for infection, added Salzman.

LEDs are light sources releasing energy in the form of photons. They release long wavelengths of light that stimulate cells to aid in healing. HEALS technology allows LED chips to function at their maximum irradiancy without emitting heat. NASA is interested in using HEALS technology for medical uses to improve healing in space and for long-term human spaceflight.

Ron Ignatius, founder and chairman of Quantum Devices Inc., of Barneveld Wis., developed the WARP 75 light delivery system for use in the trial. The device uses the HEALS technology to provide intense light energy: the equivalent light energy of 12 suns from each of the 288 LED chips – each the size of a grain of salt. It is one of many devices using HEALS technology, developed in collaboration with NASA.

In the early 1990s, Quantum teamed with the Wisconsin Center for Space Automation and Robotics – a NASA-sponsored research center at the University of Wisconsin-Madison – to develop Astroculture 3, a plant growth chamber using near infrared HEALS technology for plant growth experiments on shuttle missions. Over the years, Quantum has worked to develop HEALS technology for use in medical fields, specifically with pediatric brain tumors and hard-to-heal wounds such as diabetic skin ulcers, serious burns and oral mucositis.

“With the help of NASA’s Innovative Partnerships Program, Quantum Devices and its medical partners have been able to take a space technology and adapt it for an entirely different application to significantly help people here on Earth,” said Glenn Ignatius, president of Quantum Devices. “This collaboration between NASA and commercial companies has spurred innovation that is touching millions of lives on Earth – for the better.”

The clinical trial was funded by NASA’s Innovative Partnerships Program at the Marshall Space Flight Center in Huntsville, Ala. It included 20 cancer patients from Children’s Hospital of Wisconsin and 60 cancer patients from the University of Alabama at Birmingham Hospital and the Children’s Hospital of Alabama, also in Birmingham. The trial was the brainchild of Brian Hodgson, DDS, a pediatric dentist at Marquette University and Children’s Hospital of Wisconsin – both in Milwaukee, Wis. Dr. Harry T. Whelan, Bleser Professor of Neurology at the Medical College of Wisconsin, served as the clinical trial principal investigator at Medical College of Wisconsin and Children’s Hospital of Wisconsin.

Patients participated in the multi-center, double-blind, placebo-controlled research study – a way of testing a medical therapy where some groups receive treatment and others receive a placebo treatment that is designed to have no real effect. Participants were randomly placed in one of four study groups: low- and high-risk patients receiving the experimental light therapy through the WARP 75 device, and other low- and high-risk patients receiving light through a similar device without therapeutic effects. The low-risk patients were those whose chemotherapy and radiation treatment tended to cause mild or no mucositis and the high-risk patients were those whose therapy treatment tended to cause severe cases of mucositis.

Patients received the light therapy by a nurse holding the WARP 75 device – about the size of an adult human hand – in close proximity to the outside of the patient’s left and right cheek and neck area for 88 seconds each, daily for 14 days at the start of the patient’s bone marrow or stem cell transplant. During that time, trained clinicians assessed the patient’s mouth and patients completed a simple form to indicate their level of pain.

“NASA is proud to be a part of the HEALS technology medical advancements that are improving the lives of cancer patients and providing new, innovative medical applications,” said Helen Stinson, technical monitor for the NASA HEALS contract. “It’s exciting to see the spinoffs from NASA’s science and technology initiatives continually improve the quality of life for people here on Earth.”

The WARP 75 device is currently undergoing Food and Drug Administration premarket approval.

Photo release http://www.nasa.gov/centers/marshall/multimedia/photos/2011/photos11-023.html

Videofile http://www.nasa.gov/multimedia/videogallery/index.html?media_id=67915011

View full post on technology – Yahoo! News Search Results

NASA Light Technology Successfully Reduces Cancer Patients’ Painful Side Effects from Radiation and Chemotherapy

Friday, March 4th, 2011

image

HUNTSVILLE, Ala. – A NASA technology originally developed for plant growth experiments on space shuttle missions has successfully reduced the painful side effects resulting from chemotherapy and radiation treatment in bone marrow and stem cell transplant patients.

In a two-year clinical trial, cancer patients undergoing bone marrow or stem cell transplants were given a far red/near infrared Light Emitting Diode treatment called High Emissivity Aluminiferous Luminescent Substrate, or HEALS, to treat oral mucositis – a common and extremely painful side effect of chemotherapy and radiation treatment. The trial concluded that there is a 96 percent chance that the improvement in pain of those in the high-risk patient group was the result of the HEALS treatment.

“Using this technology as a healing agent was phenomenal,” said Dr. Donna Salzman, clinical trial principal investigator and director of clinical services and education at the Bone Marrow Transplant and Cellular Therapy Unit at the University of Alabama at Birmingham Hospital. “The HEALS device was well tolerated with no adverse affects to our bone marrow and stem cell transplant patients.”

The HEALS device, known as the WARP 75 light delivery system, can provide a cost-effective therapy since the device itself is less expensive than a day at the hospital and a proactive therapy for symptoms of mucositis that are currently difficult to treat without additional, negative side effects.

The device could offer patients several benefits: better nutrition since eating can be difficult with painful mouth and throat sores; less narcotic use to treat mouth and throat pain; and an increase in patient morale – all of which can contribute to shorter hospital stays and less potential for infection, added Salzman.

LEDs are light sources releasing energy in the form of photons. They release long wavelengths of light that stimulate cells to aid in healing. HEALS technology allows LED chips to function at their maximum irradiancy without emitting heat. NASA is interested in using HEALS technology for medical uses to improve healing in space and for long-term human spaceflight.

Ron Ignatius, founder and chairman of Quantum Devices Inc., of Barneveld Wis., developed the WARP 75 light delivery system for use in the trial. The device uses the HEALS technology to provide intense light energy: the equivalent light energy of 12 suns from each of the 288 LED chips – each the size of a grain of salt. It is one of many devices using HEALS technology, developed in collaboration with NASA.

In the early 1990s, Quantum teamed with the Wisconsin Center for Space Automation and Robotics – a NASA-sponsored research center at the University of Wisconsin-Madison – to develop Astroculture 3, a plant growth chamber using near infrared HEALS technology for plant growth experiments on shuttle missions. Over the years, Quantum has worked to develop HEALS technology for use in medical fields, specifically with pediatric brain tumors and hard-to-heal wounds such as diabetic skin ulcers, serious burns and oral mucositis.

“With the help of NASA’s Innovative Partnerships Program, Quantum Devices and its medical partners have been able to take a space technology and adapt it for an entirely different application to significantly help people here on Earth,” said Glenn Ignatius, president of Quantum Devices. “This collaboration between NASA and commercial companies has spurred innovation that is touching millions of lives on Earth – for the better.”

The clinical trial was funded by NASA’s Innovative Partnerships Program at the Marshall Space Flight Center in Huntsville, Ala. It included 20 cancer patients from Children’s Hospital of Wisconsin and 60 cancer patients from the University of Alabama at Birmingham Hospital and the Children’s Hospital of Alabama, also in Birmingham. The trial was the brainchild of Brian Hodgson, DDS, a pediatric dentist at Marquette University and Children’s Hospital of Wisconsin – both in Milwaukee, Wis. Dr. Harry T. Whelan, Bleser Professor of Neurology at the Medical College of Wisconsin, served as the clinical trial principal investigator at Medical College of Wisconsin and Children’s Hospital of Wisconsin.

Patients participated in the multi-center, double-blind, placebo-controlled research study – a way of testing a medical therapy where some groups receive treatment and others receive a placebo treatment that is designed to have no real effect. Participants were randomly placed in one of four study groups: low- and high-risk patients receiving the experimental light therapy through the WARP 75 device, and other low- and high-risk patients receiving light through a similar device without therapeutic effects. The low-risk patients were those whose chemotherapy and radiation treatment tended to cause mild or no mucositis and the high-risk patients were those whose therapy treatment tended to cause severe cases of mucositis.

Patients received the light therapy by a nurse holding the WARP 75 device – about the size of an adult human hand – in close proximity to the outside of the patient’s left and right cheek and neck area for 88 seconds each, daily for 14 days at the start of the patient’s bone marrow or stem cell transplant. During that time, trained clinicians assessed the patient’s mouth and patients completed a simple form to indicate their level of pain.

“NASA is proud to be a part of the HEALS technology medical advancements that are improving the lives of cancer patients and providing new, innovative medical applications,” said Helen Stinson, technical monitor for the NASA HEALS contract. “It’s exciting to see the spinoffs from NASA’s science and technology initiatives continually improve the quality of life for people here on Earth.”

The WARP 75 device is currently undergoing Food and Drug Administration premarket approval.

Photo release http://www.nasa.gov/centers/marshall/multimedia/photos/2011/photos11-023.html

Videofile http://www.nasa.gov/multimedia/videogallery/index.html?media_id=67915011

View full post on technology – Yahoo! News Search Results

NASA Seeks High-Bandwidth Deep Space Communications – InformationWeek

Wednesday, March 2nd, 2011

The agency’s Space Technology Program issued new solicitations this week that seek a range of innovations, including a system for removing man-made debris in earth’s orbit.

NASA, Microsoft Reveal Mars In Pictures(click image for larger view)

Slideshow: NASA, Microsoft Reveal Mars In Pictures

NASA is seeking innovations in high-bandwidth space communications, the removal of orbital debris, and improved spacecraft navigation in new solicitations from its Space Technology Program.

More Government Insights
White Papers

The agency’s Office of the Chief Technologist released the proposals as part of NASA’s use of funds from the Authorization Act of 2010. NASA also created new program offices to manage human spaceflight activities it is planning as part of its fiscal 2012 budget request.

While the Space Shuttle program ended this year, NASA’s space program is moving ahead and aims to send people deeper into space with the Space Launch System, a heavy-lift rocket, and the Multi-Purpose Crew Vehicle, the agency’s next-generation human exploration spacecraft.

In a Technology Demonstration Mission Proposal (TDMP), NASA is asking firms to demonstrate high-bandwidth deep space communication, navigation, and timing technology for spacecraft that might better enable human spaceflight beyond earth’s orbit, the agency said in one of its new solicitations (pdf).

In addition to seeking technologies that enhance each function independently, NASA also is open to ideas for “systems that integrate technology developed across communication and navigation,” it said. Other technology NASA is seeking through the TDMP includes systems that remove or mitigate orbital debris that’s collected in space due to 50-plus years of space activity.

During that time, more than 500,000 man-made objects have accumulated in the orbit of the Earth, which “pose long-term dangers to current and future space missions,” according to the solicitation.

NASA also wants organizations to demonstrate advanced in-space propulsion systems; and technology that allows spacecraft to autonomously rendezvous, dock, and fly in close proximity or in formation, it said.

NASA’s Innovative Advanced Concepts program is another effort that is looking to enhance the agency’s Space Technology Program through “visionary aerospace concepts” for new space systems, according to another solicitation (pdf) released by the agency.

NIAC is seeking proposals from academic institutions and nonprofit research laboratories for two areas of research. One is what it calls “Early Stage Innovation,” which focuses on developing technology to enhance current or new missions. The other opportunity calls for proposals for “Game Changing Developments,” which should focus on capabilities that “radically change how missions are carried out, or even conceived,” according to NASA.

Federal agencies must eliminate 800 data centers over the next five years. Find how they plan to do it in the new all-digital issue of InformationWeek Government. Download it now (registration required).

This Week’s Issue

Current Government Issue

In this issue:
Open Government Reality Check: Federal agencies are making progress on the Obama administration’s Open Government Directive, but there’s still a long way to go. Here’s our list of top priorities.
Social Security’s Online Challenge: CIO Frank Baitman envisions personalized services and increased efficiencies, but the agency’s mainframe environment presents a hurdle.
And much more!
Read the Current Issue

Subscribe Now
Featured Resources

Featured Whitepaper
Cloud Primer
Cloud computing has become an all encompassing term. This whitepaper enables corporations to cut through the marketing hype and determine what cloud computing does and does not entail – even if ideas are often conflated in customers’ and prospects’ minds. The document describes the various forms that cloud computing can take and how different types of technology relate to each other.Read More »
InformationWeek Analytics

Subscribe to InformationWeek Analytics

Find hundreds of reports featuring research from your peers, and best practices from top IT pros. Subscriptions $39 per month or $399 per year.

Exclusive Research
CIO Guides
Best Practices
Technology Adoption Trends
ROI Methodologies
Sign Up

Video

View full post on technology – Google News